Hepatitis Clinical Trials

Showing 1861-1880 of 2,113 trials

Long-term Study With Clevudine

NCT00558818

A open-labeled phase lV study with 96 weeks of treatment period. The purpose of this study is to investigate safety and efficacy of clevudine in patients chronically infected with hepatitis B virus, HBeAg positive or negative.

Chronic Hepatitis B

Bukwang Pharmaceutical150 participantsStarted Jun 2007

Seoul, South Korea

UNKNOWNNA

Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease

NCT01638832

This study will evaluate the association of non-alcoholic fatty liver disease and coronary artery disease. All patients presenting for coronary angiogram will receive the following examination: * Transient Elastography and Controlled Attenuation Parameter using the FibroScan * blood examination including biochemical markers The results of non-invasive liver steatosis and fibrosis measurement are compared with the results of coronary angiogram concerning the presence or absence of coronary artery disease.

Nonalcoholic Steatohepatitis (NASH)

Johann Wolfgang Goethe University Hospital572 participantsStarted Jun 2012

Frankfurt am Main, Germany

COMPLETEDPhase 1

Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects

NCT01250366

The purpose of this study is to determine the Safety and Pharmacokinetics of Multiple Ascending Oral Doses of INX-08189 in Chronically-infected Genotype 1 HCV, Treatment-naïve Subjects.

HCV (Genotype 1)

Bristol-Myers Squibb70 participantsStarted Oct 2010

Los Angeles, California, United States • Plymouth, Minnesota, United States • San Antonio, Texas, United States +1 more locations

Long-term Study With Clevudine

Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease

Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects

Related Searches

A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects

Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive

Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy

Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive

Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders

Open-Label Hepatic Impairment Study

Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma

A Registry Study on Xiyanping(a Chinese Medicine Injection) Used in Fifty Hospitals

SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C

Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults

Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection

Acoustic Radiation Force Impulse-Imaging in Comparison to Transient Elastography for Liver Fibrosis Staging in HCV

Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B

Treatment of Recurrent Hepatitis C After Liver Transplantation

A 5-year Observational Follow-up Study to Describe Treatment Patterns in Real World of HCV Patients in China.

Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA

Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B